“Pritest has worked hard to create innovative testing products that make a positive difference in fighting the world’s most devastating diseases like Tuberculosis. We are delighted to have Gentel as a partner”, says Chris Rathe, Co-Founder and CEO of Pritest.
The advantages of Gentel’s accumulated intellectual property around nitrocellulose surface chemistry are substantial, as it offers unparalleled sensitivity and dynamic range for protein microarray applications.
“The acquisition of this additional intellectual property means we can continue to push the limits of protein microarray technology for years to come”, says G. Randall Durnell, VP, Commercial Operations of Gentel.
Gentel supplies its Protein Microarray Slides to a number of industry leading OEM partners, in addition to researchers who create their own content-based protein arrays. Gentel also uses the proprietary ultra-thin nitrocellulose surface chemistry in the APiX™ Cancer Biomarker Array Kit and in its Sample Testing and Custom Services businesses.
About Gentel Biosciences
Gentel Biosciences is a protein microarray company whose mission is to deliver new standards in discovery, medical care, and public safety and to meet the demands of the rapidly growing field of multiplex proteomics research. Visit www.gentelbio.com for more information.
About PriTest Inc.
PriTest has developed breakthrough diagnostic tests for tuberculosis infection: TBfree™ for Mycobacterium tuberculosis testing in people, and SeraLyte-Mbv™ for Mycobacterium bovis testing of livestock. Our easy-to-use pathogen detection system offers a combination of speed and sensitivity not found on the market today.
